KALA Receives FDA Fast Track Designation for KPI-012, a Human MSC-S Therapy for Persistent Corneal Epithelial Defect 眼科查看全文
KALA BIO(KALA)2023-01-05 05:18
$Kala制药(KALA)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001558370-23-000034 Act: 33 Size: 314 KB 网页链接查看全文
一周一次的见面会又来了,还是我→美股风向标。致力于追踪热门美股优质标的,挖掘更多投资机会。接下来我们来看看本周有哪些重要的标的可以关注吧! 1、Kala制药公司 $KALA 表示,FDA接受了其主要候选产品KPI-012——治疗眼睛罕见疾病的研究... 网页链接
智通财经APP获悉,专注于眼部护理的全球医疗专业公司爱尔康(ALC.US)宣布,同意从生物制药公司Kala Pharma(KALA.US)手中收购EYSUVIS(0.25%氯替泼诺混悬滴眼液)和INVELTYS(1%氯替泼诺混悬滴眼液)。 据了解,EYSUVIS是首个也是唯一一个获FD... 网页链接
$KALA BIO(KALA)$ 8-K Current report, items 1.01, 3.02, 5.03, and 9.01 Accession Number: 0001558370-24-003889 Act: 34 Size: 940 KB 网页链接
$KALA BIO(KALA)$ 8-K Current report, items 7.01 and 8.01 Accession Number: 0001558370-24-002313 Act: 34 Size: 149 KB 网页链接
$KALA BIO(KALA)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001273087-24-000050 Act: 34 Size: 81 KB 网页链接
$KALA BIO(KALA)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-023734 Act: 34 Size: 96 KB 网页链接
$KALA BIO(KALA)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001977548-24-000004 Act: 34 Size: 79 KB 网页链接
$KALA BIO(KALA)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001319244-24-000016 Act: 34 Size: 95 KB 网页链接
$KALA BIO(KALA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-000769 Size: 10 KB 网页链接
$KALA BIO(KALA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-000770 Size: 10 KB 网页链接
$KALA BIO(KALA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-000771 Size: 10 KB 网页链接
$KALA BIO(KALA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-000772 Size: 10 KB 网页链接